528 Results for "

VEGF-R2

" in MedChemExpress (MCE) Product Catalog:
Products (528)

528 Results for "VEGF-R2" in MCE Product Catalog:

2
2 Cited Publications
Referencia número: HY-10336
No. CAS: 649735-63-7
Pureza:  99.45%
Synonyms: BMS-582664
Target:  

VEGFR Autophagy

Áreas de investigación:  

Cancer

Brivanib alaninate (BMS-582664) is an ATP-competitive inhibitor against VEGFR2 with an IC50 of 25 nM; has moderate potency against VEGFR-1 and FGFR-1, but more than 240-fold against PDGFRβ .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P70552
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KDR; Fetal Liver Kinase 1; Kinase Insert Domain Receptor; Vascular Endothelial Growth Factor Receptor 2 Variant; Vascular Endothelial Growth Factor Receptor 2; Tyrosine Kinase Growth Factor Receptor; VEGFR2; Receptor Protein-Tyrosine Kinase; FLK1; Fetal L
Species:  
Human
Source:  
HEK293
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-N8342
No. CAS: 552-54-5
Rhamnazin is an orally active inhibitor of VEGFR2 signaling with an IC50 of 4.68 μM against VEGFR2 kinase. Rhamnazin shows potent antiangiogenic activity and antitumor efficacy . Rhamnazin shows antioxidant and anti-inflammatory properties [2].
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P1663
No. CAS: 272121-15-0
Target:  

VEGFR

Áreas de investigación:  

Others

ATWLPPR Peptide is a biological active peptide. (This peptide is a specific VEGFR2/KDR heptapeptide antagonist, it binds VEGFR2 (KDR/flk), completely inhibiting VEGF binding to KDR and preventing VEGF-induced angiogenesis in-vivo. It specifically inhibits human endothelial cell proliferation in-vitro and totally abolishes VEGF-induced angiogenesis in-vivo.)
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P9920A
No. CAS: 947687-13-0

Target:  

VEGFR

Áreas de investigación:  

Cancer

Ramucirumab (anti-VEGFR) is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab (anti-VEGFR) is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D. Ramucirumab (anti-VEGFR) is also an angiogenesis inhibitor [2].
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-15992
No. CAS: 894783-71-2
Target:  

VEGFR

Áreas de investigación:  

Cancer

BIBF 1202 is the carboxylate metabolite of Nintedanib (HY-50904) which inhibits VEGFR2 kinase with an IC50 of 62 nM.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-109020
No. CAS: 1229453-99-9
Pureza:  99.84%
Synonyms: LHA510
Target:  

VEGFR

Áreas de investigación:  

Others

Acrizanib (LHA510) is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-VEGFR-2 .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-U00437
No. CAS: 1800505-64-9
Target:  

RET VEGFR Trk Receptor

Áreas de investigación:  

Cardiovascular Disease Cancer

Pz-1 is a potent RET and VEGFR2 inhibitor with IC50s of less than 1 nM for both wild type kinases.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-16025
No. CAS: 939805-30-8
Synonyms: ACTB-1003
Target:  

FGFR VEGFR

Áreas de investigación:  

Cancer

EOC317 (ACTB-1003) is an oral kinase inhibitor with IC50s of 6, 2 and 4 nM for FGFR1, VEGFR2 and Tie-2.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-10501
No. CAS: 627908-92-3
Pureza:  99.11%
Target:  

PDGFR VEGFR c-Kit

Áreas de investigación:  

Cancer

SU14813 is a multi-targeted receptor tyrosine kinases inhibitor with IC50s of 50, 2, 4, 15 nM for VEGFR2, VEGFR1, PDGFRβ and KIT.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-10497
No. CAS: 1174046-72-0
Pureza:  99.52%
Target:  

c-Met/HGFR VEGFR

Áreas de investigación:  

Cancer

BMS-794833 is a VEGFR2 and Met inhibitor extracted from patent WO2009094417, compound example 1; has IC50s of 15 and 1.7 nM, respectively.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-10527
No. CAS: 332012-40-5
Pureza:  99.37%
Synonyms: Bay 57-9352
Target:  

c-Kit PDGFR VEGFR

Áreas de investigación:  

Cancer

Telatinib (Bay 57-9352) is an orally active, small molecule inhibitor of VEGFR2, VEGFR3, PDGFα, and c-Kit with IC50s of 6, 4, 15 and 1 nM, respectively.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-10527C
No. CAS: 332013-26-0
Pureza:  99.74%
Synonyms: Bay 57-9352 mesylate
Target:  

VEGFR PDGFR c-Kit

Áreas de investigación:  

Cancer

Telatinib mesylate (Bay 57-9352 mesylate) is a potent and orally active VEGFR2, VEGFR3, PDGFα, and c-Kit inhibitor with IC50s of 6 nM, 4 nM, 15 nM and 1 nM, respectively .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-107145
No. CAS: 1394820-77-9
Pureza:  99.59%
Áreas de investigación:  

Cancer

Ningetinib Tosylate is a potent, orally bioavailable small molecule tyrosine kinase inhibitor (TKI) with IC50s of 6.7, 1.9 and <1.0 nM for c-Met, VEGFR2 and Axl, respectively.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-107145A
No. CAS: 1394820-69-9
Pureza:  99.82%
Áreas de investigación:  

Cancer

Ningetinib is a potent, orally bioavailable small molecule tyrosine kinase inhibitor (TKI) with IC50s of 6.7, 1.9 and <1.0 nM for c-Met, VEGFR2 and Axl, respectively.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-15506
No. CAS: 1005780-62-0
Pureza:  99.66%
Target:  

PDGFR VEGFR

Áreas de investigación:  

Cancer

TAK-593 is a potent VEGFR and PDGFR family inhibitor with IC50s of 3.2, 0.95, 1.1, 4.3 and 13 nM for VEGFR1, VEGFR2, VEGFR3, PDFGRα and PDFGRβ, respectively.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-B0791
No. CAS: 1345847-93-9
Synonyms: DCC-2701
Áreas de investigación:  

Cancer

Altiratinib (DCC-2701) is a multi-targeted kinase inhibitor with IC50s of 2.7, 8, 9.2, 9.3, 0.85, 4.6, 0.83 nM for MET, TIE2, VEGFR2, FLT3, Trk1, Trk2, and Trk3 respectively.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-108801
No. CAS: 862111-32-8
Synonyms: VEGF Trap; VEGF-TRAPR1R2; VEGF-trapR1

Target:  

VEGFR

Áreas de investigación:  

Cardiovascular Disease Metabolic Disease Cancer

Aflibercept is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease [2] .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-121356
No. CAS: 90729-42-3
Pureza:  99.23%
Carebastine is an Ebastine (HY-B0674) metabolite and H1-receptor antagonist. Carebastine inhibits VEGFR-2 and Akt phosphorylation. Carebastine exerts an anti-inflammatory effect by inhibiting MIF as well as TNF-α and IL-6 production. Carebastine shows anti-angiogenic activity [2]
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-108801A
No. CAS: 862111-32-8
Pureza:  97.66%

Target:  

VEGFR

Áreas de investigación:  

Cardiovascular Disease Cancer

Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease [2] .
loading...
    loading...